Literature DB >> 15669673

Improvement of CDG diagnosis by combined examination of several glycoproteins.

J Fang1, V Peters, B Assmann, C Körner, G F Hoffmann.   

Abstract

Congenital disorders of glycosylation (CDG) represent a family of genetic diseases with broad clinical presentation. Initial diagnosis is currently mainly based on the identification of hyposialylated serum transferrin (TF) by isoelectric focusing (IEF). To improve the diagnosis of known CDG types and to identify so far unknown CDG cases, additional glycoproteins, alpha1-antitrypsin titrypsin (alpha1-AT) and alpha1-antichymotrypsin (alpha1-ACT), were studied. According to the patterns of transferrin, enzyme assays and mutation analysis, 16 patients with various clinical symptoms suspicious for CDG were divided into three groups: group A (n = 6) with confirmed CDG; group B (n = 4) with clear abnormal TF-IEF patterns of unknown origin (all known CDG types were excluded) and group C (n = 6) with borderline TF-IEF patterns; 164 samples served as a control group. Automated IEF of TF, alpha1-AT and alpha1-ACT was carried out using a PhastSystem. CDG patients with glycosylation defects of known origin (group A) and patients with abnormal TF-IEF patterns due to glycosylation defects of as yet unknown origin (group B) showed abnormal IEF patterns of all three glycoproteins. These results confirmed generalized defects of glycosylation. Furthermore, the IEF pattern of alpha1-ACT seems to allow a differentiation between CDG Ia and CDG Ic. However, patients with borderline TF-IEF pattern (group C) showed a normal alpha1-AT-IEF pattern. Four of these six patients also showed a normal alpha1-ACT-IEF pattern; this constellation suggests that CDG can most likely be excluded. In the two remaining patients of group C with a borderline TF-IEF pattern an abnormal pattern of alpha1-ACT-IEF was obtained which needs further investigations. We conclude that the combined investigation of three glycoproteins provides additional information in the diagnostic work-up of patients with possible CDG. The suspicion of CDG in patients with apparent glycosylation defects of unknown origin or borderline TF-IEF pattern can be either substantiated or weakened.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15669673     DOI: 10.1023/b:boli.0000042982.82131.a4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

1.  Increased carbohydrate-deficient transferrin concentration and abnormal protein glycosylation of unknown etiology in a patient with achondroplasia.

Authors:  B Assmann; R Hackler; V Peters; J R Schaefer; G F Hoffmann
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

2.  [Diagnosis and nosology of glycanosis CDG ("carbohydrate deficient glycoprotein syndrome")].

Authors:  K Heyne; S Weidinger
Journal:  Monatsschr Kinderheilkd       Date:  1992-11       Impact factor: 0.323

3.  Multiple serum protein abnormalities in carbohydrate-deficient glycoprotein syndrome: pathognomonic finding of two-dimensional electrophoresis?

Authors:  H H Harrison; K L Miller; M D Harbison; A E Slonim
Journal:  Clin Chem       Date:  1992-07       Impact factor: 8.327

4.  Carbohydrate-deficient glycoprotein syndrome type V: deficiency of dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase.

Authors:  C Körner; R Knauer; U Holzbach; F Hanefeld; L Lehle; K von Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 5.  The carbohydrate-deficient glycoprotein syndromes: pre-Golgi and Golgi disorders?

Authors:  J Jaeken; H Carchon; H Stibler
Journal:  Glycobiology       Date:  1993-10       Impact factor: 4.313

6.  Carbohydrate-deficient glycoprotein syndrome: normal glycosylation in the fetus.

Authors:  P Clayton; B Winchester; E Di Tomaso; E Young; G Keir; C Rodeck
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

7.  Defective galactosylation of serum transferrin in galactosemia.

Authors:  J Charlwood; P Clayton; G Keir; N Mian; B Winchester
Journal:  Glycobiology       Date:  1998-04       Impact factor: 4.313

8.  Isoforms and levels of transferrin, antithrombin, alpha(1)-antitrypsin and thyroxine-binding globulin in 48 patients with carbohydrate-deficient glycoprotein syndrome type I.

Authors:  H Stibler; U Holzbach; B Kristiansson
Journal:  Scand J Clin Lab Invest       Date:  1998-02       Impact factor: 1.713

9.  Semi-automated rapid isoelectric focusing of apolipoproteins C from human plasma using Phastsystem and immunofixation.

Authors:  B Noll; R Hackler; M Pelzer; S Pelzer; P Nusser; B Maisch; J R Schaefer; A Steinmetz
Journal:  Clin Chem Lab Med       Date:  1999-06       Impact factor: 3.694

10.  Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS.

Authors:  M Aebi; A Helenius; B Schenk; R Barone; A Fiumara; E G Berger; T Hennet; T Imbach; A Stutz; C Bjursell; A Uller; J G Wahlström; P Briones; E Cardo; P Clayton; B Winchester; V Cormier-Dalre; P de Lonlay; M Cuer; T Dupré; N Seta; T de Koning; L Dorland; F de Loos; L Kupers
Journal:  Glycoconj J       Date:  1999-11       Impact factor: 2.916

View more
  1 in total

1.  Screening for congenital disorders of glycosylation in the first weeks of life.

Authors:  Christian Thiel; Dorothea Meßner-Schmitt; Georg F Hoffmann; Christian Körner
Journal:  J Inherit Metab Dis       Date:  2012-09-19       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.